Mode
Text Size
Log in / Sign up

tDCS is the most efficacious standalone non-invasive brain stimulation for autism social cognitionBrain stimulation shows promise for social skills in autism

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider tDCS as the most efficacious standalone NIBS intervention for improving social cognition in autism.

This network meta-analysis synthesized data from 50 randomized controlled trials to evaluate the efficacy of various non-invasive brain stimulation (NIBS) modalities, including tDCS, HF-rTMS, LF-rTMS, and TBS, alongside digital interventions for social cognition in individuals with autism spectrum disorder. The analysis utilized the CINEMA assessment to evaluate evidence certainty.

Findings indicate that tDCS outperformed treatment as usual with an effect size of SMD=-1.69 (95% CrI: -2.67, -0.70) and a SUCRA of 88.24%. HF-rTMS also outperformed treatment as usual (SMD=-1.60, 95% CrI: -2.32, -0.89; SUCRA = 84.38%). LF-rTMS (SMD=-1.36, 95% CrI: -1.77, -0.96; SUCRA = 74.22%) and TBS (SMD=-1.19, 95% CrI: -2.02, -0.35; SUCRA = 64.21%) also showed improvements over treatment as usual.

The authors note that while tDCS is the most efficacious standalone intervention, further large-scale, rigorous RCTs are required to validate these modalities and potential combined protocols. Clinically, tDCS or TBS may be considered for social cognitive deficits, with a recommendation to explore synergistic paradigms combining NIBS neural priming with digital training.

How this fits prior evidence

This finding addresses a gap in non-pharmacological interventions for autism. While GABA-modulating pharmacotherapies showed inconsistent results for improving symptoms, this meta-analysis suggests tDCS and other NIBS modalities may offer more consistent improvements in social cognition. This adds to the evidence base alongside structured physical activity, which provides multidimensional benefits for individuals with autism spectrum disorder.

Navigating social interactions can be a significant challenge for people living with autism spectrum disorder. Researchers recently looked at 50 different trials to see if non-invasive brain stimulation (NIBS) could help improve social cognition, which is the ability to process and understand social information.

The study compared several types of brain stimulation against standard care. They found that transcranial direct current stimulation (tDCS) was the most effective standalone method for improving social skills. Other methods, including high-frequency and low-frequency repetitive transcranial magnetic stimulation (rTMS), also showed better results than standard care. These methods use magnetic fields or low-level currents to stimulate specific areas of the brain.

While these results are encouraging, the researchers noted that more large-scale, rigorous trials are needed. These future studies will help confirm how well these treatments work on their own and how they might work even better when combined with digital training programs. Talk to a doctor to see if these options are right for a specific individual.

What this means for you:
Certain types of brain stimulation, especially tDCS, show the most promise for improving social skills in autism.

Common questions

What is tDCS and does it help with autism?

tDCS stands for transcranial direct current stimulation. It is a non-invasive way to stimulate the brain using a small amount of electricity. In this study of 50 trials, tDCS was found to be the most effective standalone method for improving social cognition in people with autism.

Are there other types of brain stimulation that work?

Yes, other methods also showed improvement over standard care. These include high-frequency repetitive transcranial magnetic stimulation (HF-rTMS), low-frequency repetitive transcranial magnetic stimulation (LF-rTMS), and theta burst stimulation (TBS). Each of these methods showed positive results for social cognition.

Is this treatment ready for everyone with autism?

The results are promising, but the researchers noted that more large-scale, rigorous trials are still needed. These future studies will help confirm the best ways to use these tools alone or combined with digital training. You should consult a medical professional to discuss these options.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
IntroductionTo evaluate the relative efficacy of non-invasive brain stimulation (NIBS) and digital interventions for improving social cognition in autism spectrum disorder (ASD).MethodsA systematic search of PubMed, Embase, Web of Science, Cochrane, CNKI to February 2026 yielded 50 randomized controlled trials (RCTs). A Bayesian network meta-analysis was performed using R, ranking interventions via Surface Under the Cumulative Ranking curve (SUCRA) and assessing evidence certainty with Confidence in Network Meta-Analysis (CINEMA).ResultsAcross the included trials (mean age range: 2.54 to 20.80 years), among 9 interventions, transcranial direct current stimulation (tDCS) emerged as optimal (SUCRA = 88.24%), significantly outperforming treatment as usual (TAU) (SMD=-1.69, 95% CrI: -2.67, -0.70). This was followed by high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) (84.38%, SMD=-1.60, 95% CrI: -2.32, -0.89), low-frequency repetitive transcranial magnetic stimulation (LF-rTMS) (74.22%, SMD=-1.36, 95% CrI: -1.77, -0.96), and theta-burst stimulation (TBS) (64.21%, SMD=-1.19, 95% CrI: -2.02, -0.35); all significantly outperformed TAU. Standalone digital interventions ranked lower. Meta-regression showed no significant age moderating effect.ConclusionstDCS is the most efficacious standalone intervention for ASD social cognitive deficits. We recommend tDCS or TBS clinically and advocate a synergistic paradigm integrating NIBS neural priming with digital training. However, future large-scale, rigorous RCTs are required to further validate both these standalone modalities and the proposed combined protocols.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420261337491, identifier CRD420261337491.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.